MULTIPLE SCLEROSIS (MS)
Clinical trials for MULTIPLE SCLEROSIS (MS) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with MS: major drug showdown aims to slash relapses
Disease control OngoingThis study tests two newer multiple sclerosis drugs, ofatumumab and siponimod, against an older one, fingolimod, in 129 children and teens aged 10 to 17. The goal is to see which medicine better prevents MS relapses over two years. Participants must have had recent relapses or ne…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
New study tracks daily life changes in MS patients on ofatumumab
Knowledge-focused OngoingThis study follows 302 adults with multiple sclerosis in France who are starting ofatumumab as part of their normal care. Researchers will use questionnaires to measure how the treatment affects quality of life over 12 months. The goal is to understand real-world benefits, not to…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 05:23 UTC
-
MS drug use in late pregnancy under review: is it safe?
Knowledge-focused OngoingThis study checks how many women with multiple sclerosis (MS) used the drug interferon-beta during the second and third trimesters of pregnancy in Finland and Sweden. Researchers want to see if there are enough cases to study whether the drug affects pregnancy outcomes like birth…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC